What Yarrow Bioscience, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 1 | 18 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 2,566 |
| Disposed | 11,107 | 28,860 |
| Net activity | −11,107 | −26,294 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Rtw Fund Group GP, Llc | 10% owner | Jul 29 | Other Transaction · J | −133,290 | — | — | 266,307 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Jul 23 | Withheld — tax / exercise cost · F | −22,516 | $0.90 | −$20.2K | 95,918 |
| Domzalski David | PRESIDENT AND CEO | Jul 23 | Withheld — tax / exercise cost · F | −79,391 | $0.90 | −$71.3K | 347,174 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Jul 23 | Withheld — tax / exercise cost · F | −22,516 | $0.90 | −$20.2K | 74,918 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Jul 23 | Withheld — tax / exercise cost · F | −15,405 | $0.90 | −$13.8K | 95,944 |
| Domzalski David | PRESIDENT AND CEO | Jun 30 | Withheld — tax / exercise cost · F | −12,214 | $0.65 | −$7.95K | 426,565 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Jun 30 | Withheld — tax / exercise cost · F | −2,370 | $0.65 | −$1.54K | 111,349 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Jun 30 | Withheld — tax / exercise cost · F | −3,464 | $0.65 | −$2.25K | 118,434 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Jun 30 | Withheld — tax / exercise cost · F | −3,464 | $0.65 | −$2.25K | 97,434 |
| Domzalski David | PRESIDENT AND CEO | May 29 | Grant / award · A | +30,791 | $0.31 | +$9.55K | 438,779 |
| Domzalski David | PRESIDENT AND CEO | Mar 31 | Withheld — tax / exercise cost · F | −14,232 | $0.60 | −$8.5K | 401,976 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Mar 31 | Withheld — tax / exercise cost · F | −4,007 | $0.60 | −$2.39K | 121,898 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Mar 31 | Withheld — tax / exercise cost · F | −2,876 | $0.60 | −$1.72K | 112,363 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Mar 31 | Withheld — tax / exercise cost · F | −4,007 | $0.60 | −$2.39K | 99,788 |
| Stuart Iain | CHIEF SCIENTIFIC OFFICER | Dec 31 | Withheld — tax / exercise cost · F | −2,448 | $0.58 | −$1.42K | 115,239 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Dec 31 | Withheld — tax / exercise cost · F | −3,579 | $0.58 | −$2.08K | 125,905 |
| Zeronda Tyler | CHIEF FINANCIAL OFFICER | Dec 31 | Withheld — tax / exercise cost · F | −7,858 | $0.58 | −$4.56K | 103,795 |
| Domzalski David | PRESIDENT AND CEO | Dec 31 | Withheld — tax / exercise cost · F | −12,684 | $0.58 | −$7.36K | 416,208 |
| Harsch Mutya | CHIEF LEGAL OFFICER AND GC | Sep 30 | Withheld — tax / exercise cost · F | −3,581 | $0.34 | −$1.2K | 129,484 |
| Domzalski David | PRESIDENT AND CEO | Sep 30 | Withheld — tax / exercise cost · F | −12,676 | $0.34 | −$4.25K | 428,892 |
Loading...